Home・Список акций・Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

Закрыт

СекторЗдравоохранение

23.28 -0.68

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

22.62

Макс.

23.57

Ключевые показатели
By Trading Economics
Доход	-775K -21M
Продажи	7.3M 255M
Прибыль на акцию	-0.31
Рентабельность продаж	-8.316
Сотрудники	2,500
EBITDA	4.5M -9.2M

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+12.2% upside

Дивиденды
By Acuity
Следующий отчет о доходах	5 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	209M 1.6B
Предыдущая цена открытия	23.96
Предыдущая цена закрытия	23.28

Новостные настроения

By Acuity

50%

152 / 340 Рейтинг в Healthcare

Tandem Diabetes Care Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

12 авг. 2026 г., 19:41 UTC

News

Tandem Diabetes Care reported a narrower second-quarter loss of 31 cents per share, with revenues of $254.6 million, as shares rise since Tuesday.

11 авг. 2026 г., 19:46 UTC

News

Tandem Diabetes Care reported improved second-quarter results, including a narrower loss and increased revenue, supporting shares' advance during Tuesday's session.

10 авг. 2026 г., 19:36 UTC

News

Tandem Diabetes Care reported second-quarter revenue of $254.6 million and reaffirmed its full-year guidance of $1.08 billion, supporting a higher share price today.

7 авг. 2026 г., 20:02 UTC

News

Tandem Diabetes Care shares rose after Q2 sales of $254.6 million and adjusted EBITDA of $6.4 million exceeded forecasts, despite RBC lowering its price target to $26.

6 авг. 2026 г., 23:02 UTC

News

Tandem Diabetes Care reported Q2 sales of $254.6 million and reaffirmed revenue guidance, with shares trading higher in after-market hours.

5 авг. 2026 г., 19:56 UTC

News

Tandem Diabetes Care Inc's shares are declining amid negative sentiment in the insulin sector following Insulet Corp's lowered revenue growth forecast.

4 авг. 2026 г., 19:46 UTC

Tandem Diabetes Care Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. Earlier, the stock reached a session high before pulling back.

31 июл. 2026 г., 19:51 UTC

Tandem Diabetes Care Inc is advancing today, benefiting from positive market sentiment driven by technology stocks, despite pulling back from earlier session highs.

30 июл. 2026 г., 17:11 UTC

Tandem Diabetes Care shares are lower today as the Health Care Equipment sub-sector declines. The asset remains above its 20-day moving average.

29 июл. 2026 г., 18:15 UTC

Tandem Diabetes Care Inc. shares are higher, driven by significant gains in Health Care Equipment stocks, despite a recent trend of daily price increases.

27 июл. 2026 г., 19:21 UTC

Tandem Diabetes Care Inc. shares are lower, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

24 июл. 2026 г., 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21 июл. 2026 г., 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20 июл. 2026 г., 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Сравнение c конкурентами

Изменение цены

Tandem Diabetes Care Inc Прогноз

Целевая цена

By TipRanks

12.2% рост

Прогноз на 12 месяцев

Средняя 26.3 USD 12.2%

Максимум 50 USD

Минимум 15.5 USD

Основано на мнении 15 аналитиков Wall Street, спрогнозировавших целевые цены для Tandem Diabetes Care Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

15 ratings

Покупка

Удержание

Продажа

Основано на мнении 15 аналитиков, присваивавших рейтинги акциям Tandem Diabetes Care Inc – Данные за последние 3 месяца.

Настроения

By Acuity

152 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.